...
首页> 外文期刊>Cancer gene therapy >Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L
【24h】

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

机译:用表达膜结合或分泌的GITR-L的重组腺病毒构建体绕过肿瘤相关的免疫抑制

获取原文
           

摘要

Recent evidence has resurrected the concept of specialized populations of T lymphocytes that are able to suppress an antigen-specific immune response. T-regulatory cells (T-reg) have been characterized as CD4+ CD25+ T cells. Previous reports describing differential gene expression analysis have shown that the glucocorticoid-induced tumor necrosis family receptor family-related gene (GITR) is upregulated in these cells. Furthermore, antibodies specific for GITR have been shown to inhibit the T-suppressor function of CD4+ CD25+ T-reg. The ligands for both mouse and human GITR have been cloned recently. We have inserted the sequences for natural, membrane-bound GITR-ligand (GITR-L) and a truncated secreted form of GITR-L (GITR-Lsol) into the adenovirus-5 genome. Coculture experiments show that cells infected with Ad-GITR-L and supernatants from cells infected with Ad-GITR-Lsol can increase the proliferation of both CD4+ CD25- and CD8+ T cells in response to anti-CD3 stimulation, in the presence, as well as in the absence, of CD4+ CD25+ T cells. The virus constructs were injected into growing B16 melanoma tumors. Ad-GITR-L was shown to attract infiltration with both CD4+ and CD8+ T cells. Both constructs were shown to inhibit tumor growth.
机译:最近的证据已经复活了能够抑制抗原特异性免疫反应的T淋巴细胞专门种群的概念。 T调节细胞(T-reg)已被表征为CD4 + CD25 + T细胞。先前描述差异基因表达分析的报告显示,糖皮质激素诱导的肿瘤坏死家族受体家族相关基因(GITR)在这些细胞中上调。此外,已证明对GITR有特异性的抗体可抑制CD4 + CD25 + T-reg的T抑制子功能。最近已经克隆了小鼠和人GITR的配体。我们已经将天然的,膜结合的GITR-配体(GITR-L)和GITR-L(GITR-Lsol)的截短分泌形式的序列插入了腺病毒5基因组中。共培养实验表明,感染Ad-GITR-L的细胞和感染Ad-GITR-Lsol的细胞的上清液也可以在存在抗CD3刺激的情况下增加CD4 + CD25-和CD8 + T细胞的增殖。就像没有CD4 + CD25 + T细胞一样。将病毒构建体注射到生长中的B16黑色素瘤肿瘤中。显示Ad-GITR-L吸引CD4 +和CD8 + T细胞的浸润。两种构建体均显示抑制肿瘤生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号